DIVESTITURES (Details) (USD $) In Millions, unless otherwise specified	0 Months Ended	3 Months Ended	0 Months Ended	3 Months Ended	1 Months Ended		3 Months Ended
	Jul. 10, 2014 Filler and Toxin Group	Sep. 30, 2014 Filler and Toxin Group	Jul. 01, 2014 Metronidazole 1.3 Percent Vaginal Gel Antibiotic Development Product	Sep. 30, 2014 Metronidazole 1.3 Percent Vaginal Gel Antibiotic Development Product	Jul. 31, 2014 PreCision Tretin-X Cream Products	Jul. 31, 2014 Precision Generic Tretinoin Products	Sep. 30, 2014 Precision Generic Tretinoin Products
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from divestiture of businesses	$ 1,400.0		$ 10.0		$ 70.0	$ 45.0
Gain (loss) on sale of business		323.9		(58.5)			(8.8)
Disposal group, costs to sell for divestiture		$ 43
Period of payment of minimum royalties from commercialization of development product			3 years